Suppression of intrahepatic cholangiocarcinoma cell growth by <scp>SKI</scp> via upregulation of the <scp>CDK</scp> inhibitor p21-Reference-Cited by-同舟云学术

Suppression of intrahepatic cholangiocarcinoma cell growth by SKI via upregulation of the CDK inhibitor p21

Published:2022-09-26 Issue:12 Volume:12 Page:2122-2135
ISSN:2211-5463
Container-title:FEBS Open Bio
language:en
Short-container-title:FEBS Open Bio

Author:

Kawamura Etsushi¹^ORCID,Matsubara Tsutomu²,Daikoku Atsuko²,Deguchi Sanae¹,Kinoshita Masahiko³,Yuasa Hideto²,Urushima Hayato²,Odagiri Naoshi¹,Motoyama Hiroyuki¹,Kotani Kohei¹,Kozuka Ritsuzo¹,Hagihara Atsushi¹,Fujii Hideki¹,Uchida‐Kobayashi Sawako¹,Tanaka Shogo³,Takemura Shigekazu³,Iwaisako Keiko⁴,Enomoto Masaru¹,Taguchi Y. H.⁵,Tamori Akihiro¹,Kubo Shoji³,Ikeda Kazuo²,Kawada Norifumi¹

Affiliation:

1. Department of Hepatology, Graduate School of Medicine Osaka Metropolitan University Japan

2. Department of Anatomy and Regenerative Biology, Graduate School of Medicine Osaka Metropolitan University Japan

3. Department of Hepato‐Biliary‐Pancreatic Surgery, Graduate School of Medicine Osaka Metropolitan University Japan

4. Department of Medical Life Systems Doshisha University Graduate School of Life and Medical Sciences Kyoto Japan

5. Department of Physics Chuo University Tokyo Japan

Funder

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

General Biochemistry, Genetics and Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/2211-5463.13489

Reference42 articles.

1. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017

2. Cholangiocarcinoma

3. Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection

4. Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study

5. Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic Characterization of Intrahepatic Cholangiocarcinoma Identifies Distinct Subgroups and Proteins Associated with Time-To-Recurrence;2024-02-29

2. New Era of Immune-Based Therapy in Intrahepatic Cholangiocarcinoma;Cancers;2023-08-06